Logo image of QS

QUANTUMSCAPE CORP (QS) Stock Fundamental Analysis

NYSE:QS - New York Stock Exchange, Inc. - US74767V1098 - Common Stock - Currency: USD

3.87  +0.07 (+1.84%)

After market: 3.97 +0.1 (+2.58%)

Fundamental Rating

2

QS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. While QS seems to be doing ok healthwise, there are quite some concerns on its profitability. QS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year QS has reported negative net income.
QS had a negative operating cash flow in the past year.
In the past 5 years QS always reported negative net income.
In the past 5 years QS always reported negative operating cash flow.
QS Yearly Net Income VS EBIT VS OCF VS FCFQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

QS's Return On Assets of -36.14% is on the low side compared to the rest of the industry. QS is outperformed by 93.83% of its industry peers.
QS's Return On Equity of -41.27% is on the low side compared to the rest of the industry. QS is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
ROA -36.14%
ROE -41.27%
ROIC N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
QS Yearly ROA, ROE, ROICQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

QS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QS Yearly Profit, Operating, Gross MarginsQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

6

2. Health

2.1 Basic Checks

QS has more shares outstanding than it did 1 year ago.
QS has a worse debt/assets ratio than last year.
QS Yearly Shares OutstandingQS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
QS Yearly Total Debt VS Total AssetsQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.52 indicates that QS is not in any danger for bankruptcy at the moment.
QS has a better Altman-Z score (3.52) than 81.48% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that QS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, QS belongs to the top of the industry, outperforming 90.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACCN/A
WACCN/A
QS Yearly LT Debt VS Equity VS FCFQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 14.21 indicates that QS has no problem at all paying its short term obligations.
QS has a better Current ratio (14.21) than 100.00% of its industry peers.
A Quick Ratio of 14.21 indicates that QS has no problem at all paying its short term obligations.
The Quick ratio of QS (14.21) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 14.21
Quick Ratio 14.21
QS Yearly Current Assets VS Current LiabilitesQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B

1

3. Growth

3.1 Past

QS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.08%.
EPS 1Y (TTM)2.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

QS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.98% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.13%
EPS Next 2Y8.83%
EPS Next 3Y9.15%
EPS Next 5Y16.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QS Yearly Revenue VS EstimatesQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
QS Yearly EPS VS EstimatesQS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QS Price Earnings VS Forward Price EarningsQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QS Per share dataQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.83%
EPS Next 3Y9.15%

0

5. Dividend

5.1 Amount

No dividends for QS!.
Industry RankSector Rank
Dividend Yield N/A

QUANTUMSCAPE CORP

NYSE:QS (4/22/2025, 7:00:00 PM)

After market: 3.97 +0.1 (+2.58%)

3.87

+0.07 (+1.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners33.16%
Inst Owner Change0%
Ins Owners1.11%
Ins Owner Change4.69%
Market Cap2.12B
Analysts49.41
Price Target6.03 (55.81%)
Short Float %15.03%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.07%
Min EPS beat(2)-6.33%
Max EPS beat(2)0.19%
EPS beat(4)1
Avg EPS beat(4)-6.69%
Min EPS beat(4)-12.74%
Max EPS beat(4)0.19%
EPS beat(8)3
Avg EPS beat(8)-1.4%
EPS beat(12)3
Avg EPS beat(12)-8.97%
EPS beat(16)3
Avg EPS beat(16)-28.04%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.8%
EPS NQ rev (1m)0.93%
EPS NQ rev (3m)2.93%
EPS NY rev (1m)2.04%
EPS NY rev (3m)3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.83
P/tB 1.83
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0
BVpS2.12
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.14%
ROE -41.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 94.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.21
Quick Ratio 14.21
Altman-Z 3.52
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)275.34%
Cap/Depr(5y)456.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.35%
EPS Next Y12.13%
EPS Next 2Y8.83%
EPS Next 3Y9.15%
EPS Next 5Y16.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.37%
EBIT Next 3Y15.44%
EBIT Next 5Y21%
FCF growth 1Y-3.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.39%
OCF growth 3YN/A
OCF growth 5YN/A